Hsp70 Protein Complexes as Drug Targets

Author(s): Victoria A. Assimon, Anne T. Gillies, Jennifer N. Rauch, Jason E. Gestwicki

Journal Name: Current Pharmaceutical Design

Volume 19 , Issue 3 , 2013

Become EABM
Become Reviewer

Abstract:

Heat shock protein 70 (Hsp70) plays critical roles in proteostasis and is an emerging target for multiple diseases. However, competitive inhibition of the enzymatic activity of Hsp70 has proven challenging and, in some cases, may not be the most productive way to redirect Hsp70 function. Another approach is to inhibit Hsp70’s interactions with important co-chaperones, such as J proteins, nucleotide exchange factors (NEFs) and tetratricopeptide repeat (TPR) domain-containing proteins. These co-chaperones normally bind Hsp70 and guide its many diverse cellular activities. Complexes between Hsp70 and co-chaperones have been shown to have specific functions, including roles in pro-folding, pro-degradation and pro-trafficking pathways. Thus, a promising strategy may be to block protein- protein interactions between Hsp70 and its co-chaperones or to target allosteric sites that disrupt these contacts. Such an approach might shift the balance of Hsp70 complexes and re-shape the proteome and it has the potential to restore healthy proteostasis. In this review, we discuss specific challenges and opportunities related to these goals. By pursuing Hsp70 complexes as drug targets, we might not only develop new leads for therapeutic development, but also discover new chemical probes for use in understanding Hsp70 biology.

Keywords: Heat shock protein 70, molecular chaperones, J proteins, nucleotide exchange factors, tetratricopeptide repeat domain-containing proteins, protein complex, proteostasis, co-chaperones, allosteric sites, chemical probes

Rights & PermissionsPrintExport Cite as

Article Details

VOLUME: 19
ISSUE: 3
Year: 2013
Page: [404 - 417]
Pages: 14
DOI: 10.2174/1381612811306030404
Price: $65

Article Metrics

PDF: 42